Pregnancy outcomes of women exposed to laninamivir during pregnancy

Abstract

PURPOSE The purpose of this study is to assess pregnancy outcomes of women treated with a novel neuraminidase inhibitor, laninamivir, during pregnancy. METHODS A retrospective review of pregnancy outcomes of 112 pregnant women who were given laninamivir for treatment of influenza was performed. Possible adverse events, including miscarriages, preterm… (More)
DOI: 10.1002/pds.3684

Topics

2 Figures and Tables

Cite this paper

@inproceedings{Minakami2014PregnancyOO, title={Pregnancy outcomes of women exposed to laninamivir during pregnancy}, author={Hisanori Minakami and Takahiko Kubo and Akihito Nakai and Shigeru Saito and Nobuya Unno}, booktitle={Pharmacoepidemiology and drug safety}, year={2014} }